Back
Zoetis Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
49
ZTS
Zoetis
Last Price:
176.98
Seasonality Move:
3.66%
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
64.25
Seasonality Move:
12.47%
Sell
49
Zoetis (ZTS)
is a Sell
Is Zoetis a Buy, Sell or Hold?
- The current Zoetis [ZTS] share price is $176.96. The Score for ZTS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- ZTS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ZTS Stock Price Chart
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $64.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
ZTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.58 | Sell |
| Relative Strength Index (14 RSI): | 45.05 | Sell |
| Chaikin Money Flow: | -444556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (173.75 - 183.61) | Sell |
| Bollinger Bands (100): | (177.37 - 190.59) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 38.59 | Sell |
| Chaikin Money Flow: | 518116 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.94 - 69.24) | Sell |
| Bollinger Bands (100): | (67.93 - 87.19) | Sell |
ZTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 176.02 | Buy |
| 20-day SMA: | 176.88 | Buy |
| 50-day SMA: | 185.6 | Sell |
| 200-day SMA: | 178.25 | Sell |
| 8-day EMA: | 176.22 | Buy |
| 20-day EMA: | 177.99 | Sell |
| 50-day EMA: | 181.76 | Sell |
| 200-day EMA: | 180.47 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.73 | Buy |
| 20-day SMA: | 65.69 | Sell |
| 50-day SMA: | 68.56 | Sell |
| 200-day SMA: | 81.05 | Sell |
| 8-day EMA: | 63.9 | Buy |
| 20-day EMA: | 65.57 | Sell |
| 50-day EMA: | 69.74 | Sell |
| 200-day EMA: | 79.39 | Sell |
Zoetis Earnings Growth & ZTS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.54 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Zoetis Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||